Apteka Studenckasp. z o.o.

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2012-04-17
Share capital
531,100.00 PLN
Registered address
Langiewicza 16, 20-032 Lublin, Poland

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 92 days late).

  • 202505/07/2026
  • 202430/06/2025
  • 202330/06/2024
  • 202230/06/2023
  • 202115/10/2022
  • 202029/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 310.07kMedianUSD 917.74kAverageUSD 25.73m
Net profit
This companyUSD -17.64kMedianUSD 14.44kAverageUSD 2.75m
Operating costs
This companyUSD 327.64kMedianUSD 860.03kAverageUSD 21.34m
Assets
This companyUSD 66.67kMedianUSD 883.09kAverageUSD 31.39m

Authorized Representatives

Janusz Teodor Wargocki – Attorney-in-fact (sole)
Maria Wawruch – President of the Management Board

Manner of representation

In the case of a one-person management board, the company is represented independently by the President of the Management Board, whereas in the case of a multi-member management board, each member of the management board is authorised to make declarations and sign on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Janusz Teodor Wargockiage 60
5,311$143,462.99100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2012-05-03.

  • VeloBank
    23 1560 0013 2367 2851 1566 0001

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $3,742.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$741
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$860

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Przedsiębiorstwo Farmaceutyczne Leki Natury Tadeusz Polańskisp. z o.o.
DR Andresp. z o.o.
STEM Cells SpinS.A.
F1 PharmaS.A.
Ti-Comsp. z o.o.
LideoS.A.
Munar PharmaS.A.
BIO Animalisp. z o.o.
Ampliconsp. z o.o.
Powerpharmasp. z o.o.

Change history

DateEvent
2012-05-29Address change
2012-05-29Share capital increase
2012-04-17Entered in the register

FAQ

Last updated: 2026-07-05